A combination of timely interventions now and proactive protocols next winter can benefit patients who experience exacerbated symptoms at certain times of the year.

The Company demonstrated strong mucoadhesion and broad surface coverage in ex vivo nasal tissue models Raanana, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the ...

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

The studies were conducted in collaboration with Prof. Fabio Sonvico's laboratory, utilizing excised rabbit nasal mucosa as a surrogate for human nasal tissues. The research aimed to characterize two ...

Most vaccines — and boosters — are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease.

Most vaccines -- and boosters -- are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease. But for respiratory diseases ...

The new molecule, delivered via nasal spray, triggers "mucosal immunity" which coats the tissue lining organs and tracts before a virus can enter. Tests in mice showed the antibody protected ...

Conducted in collaboration with Prof. Fabio Sonvico's lab using rabbit nasal mucosa, the studies showcased how Polyrizon's formulation quickly spreads and forms a uniform layer on the nasal ...

Interest in developing nasal dosage forms has increased significantly in the last two years, driven by a number of recent ...